The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarillion Plc Regulatory News (CLLN)

  • This share is currently suspended. It was suspended at a price of 14.27

Share Price Information for Carillion Plc (CLLN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.27
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 14.27
CLLN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Balfour Beatty Plc

8 Aug 2014 10:41

RNS Number : 6491O
Morgan Stanley Securities Limited
08 August 2014
 

 

 FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley Securities Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

BALFOUR BEATTY PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

 

CARILLION PLC

(d) Date dealing undertaken:

07 AUGUST 2014

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

Yes

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

 Class of relevant security

 Purchases/sales

 Total number of securities

 Highest price per unit paid/received

 Lowest price per unit paid/received

 50P ORDINARY

 PURCHASES

 498,622

 2.3900 GBP

 2.3500 GBP

 50P ORDINARY

 SALES

 488,974

 2.3910 GBP

 2.3500 GBP

 

 

(b) Derivatives transactions (other than options)

 

 Class of relevant security

 Product description

e.g. CFD

 Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 Number of reference securities

 Price per unit

 50P ORDINARY

 CFD

 LONG

 5

 2.3540 GBP

 50P ORDINARY

 CFD

 LONG

 1,524

 2.3550 GBP

 50P ORDINARY

 CFD

 LONG

 3,620

 2.3565 GBP

 50P ORDINARY

 CFD

 LONG

 6,857

 2.3578 GBP

 50P ORDINARY

 CFD

 LONG

 22,830

 2.3578 GBP

 50P ORDINARY

 CFD

 LONG

 18,572

 2.3590 GBP

 50P ORDINARY

 CFD

 LONG

 3,508

 2.3639 GBP

 50P ORDINARY

 CFD

 LONG

 55

 2.3640 GBP

 50P ORDINARY

 CFD

 LONG

 235

 2.3642 GBP

 50P ORDINARY

 CFD

 LONG

 409

 2.3654 GBP

 50P ORDINARY

 CFD

 LONG

 762

 2.3700 GBP

 50P ORDINARY

 CFD

 LONG

 15,659

 2.3721 GBP

 50P ORDINARY

 CFD

 LONG

 238,979

 2.3721 GBP

 50P ORDINARY

 CFD

 LONG

 91

 2.3735 GBP

 50P ORDINARY

 CFD

 LONG

 2,457

 2.3744 GBP

 50P ORDINARY

 CFD

 LONG

 228

 2.3750 GBP

 50P ORDINARY

 CFD

 SHORT

 1,607

 2.3550 GBP

 50P ORDINARY

 CFD

 SHORT

 336

 2.3550 GBP

 50P ORDINARY

 CFD

 SHORT

 647

 2.3550 GBP

 50P ORDINARY

 CFD

 SHORT

 750

 2.3550 GBP

 50P ORDINARY

 CFD

 SHORT

 2,366

 2.3576 GBP

 50P ORDINARY

 CFD

 SHORT

 289

 2.3673 GBP

 50P ORDINARY

 CFD

 SHORT

 37,905

 2.3675 GBP

 50P ORDINARY

 CFD

 SHORT

 23,584

 2.3713 GBP

 50P ORDINARY

 CFD

 SHORT

 3,099

 2.3713 GBP

 50P ORDINARY

 CFD

 SHORT

 1,701

 2.3715 GBP

 50P ORDINARY

 CFD

 SHORT

 13,782

 2.3715 GBP

 50P ORDINARY

 CFD

 SHORT

 238,979

 2.3723 GBP

 50P ORDINARY

 CFD

 SHORT

 124

 2.3723 GBP

 50P ORDINARY

 CFD

 SHORT

 904

 2.3730 GBP

 50P ORDINARY

 CFD

 SHORT

 519

 2.3730 GBP

 50P ORDINARY

 CFD

 SHORT

 50

 2.3747 GBP

 50P ORDINARY

 CFD

 SHORT

 10,000

 2.3756 GBP

 50P ORDINARY

 CFD

 SHORT

 6,500

 2.3824 GBP

 50P ORDINARY

 CFD

 SHORT

 762

 2.3860 GBP

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

 Class of relevant security

 Product description e.g. call option

 Writing, purchasing, selling, varying etc.

 Number of securities to which option relates

 Exercise price per unit

 Type e.g. American, European etc.

 Expiry date

 Option money paid/ received per unit

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 

(ii) Exercising

 

 Class of relevant security

 Product description e.g. call option

 Number of securities

 Exercise price per unit

 N/A

 N/A

 N/A

 N/A

 

(d) Other dealings (including subscribing for new securities)

 

 Class of relevant security

 Nature of dealing e.g. subscription, conversion

 Details

 Price per unit (if applicable)

 N/A

 N/A

 N/A

 N/A

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

Date of disclosure:

08 AUGUST 2014

Contact name:

Darren Wickert

Telephone number:

+44 (0)20 7425 6578

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERFMGGRLRLGDZG
Date   Source Headline
3rd Apr 20187:30 amRNSUpdate re Liquidation of Carillion
19th Mar 20187:00 amRNSFRC investigation
17th Jan 20188:15 amRNSAnnouncement Re. Carillion PLC
15th Jan 20187:45 amRNSSuspension - Carillion PLC
15th Jan 20187:00 amRNSCompulsory liquidation of Carillion
12th Jan 20186:08 pmRNSUpdate on discussions with creditors
12th Jan 20185:08 pmRNSHolding(s) in Company
10th Jan 20185:48 pmRNSHolding(s) in Company
9th Jan 20187:03 amRNSResponse to share price movement
3rd Jan 20184:44 pmRNSHolding(s) in Company
3rd Jan 20187:00 amRNSRegulatory investigation
22nd Dec 20177:00 amRNSUpdate on financial covenant deferral
20th Dec 201710:16 amRNSBlock listing Interim Review
20th Dec 20177:00 amRNSChief Executive Appointment
13th Dec 20177:00 amRNSUpdate on UK healthcare facilities business
11th Dec 20177:58 amRNSHolding(s) in Company
1st Dec 20177:00 amRNSDirectorate Change
23rd Nov 201712:08 pmRNSHolding(s) in Company
22nd Nov 201712:29 pmRNSHolding(s) in Company
21st Nov 20174:11 pmRNSHolding(s) in Company
20th Nov 20177:00 amRNSFramework Award
17th Nov 20177:02 amRNSUpdate
15th Nov 20177:00 amRNSOman - letter of award for contract
6th Nov 20177:00 amRNSContract wins
2nd Nov 20177:00 amRNSDirectorate Change
31st Oct 20177:00 amRNSDisposal
27th Oct 20177:00 amRNSChief Executive Appointment
24th Oct 20177:00 amRNSUpdate on financing, disposals and work winning
12th Oct 201712:43 pmRNSUK Healthcare business
4th Oct 20172:58 pmRNSHolding(s) in Company
29th Sep 20177:00 amRNSHalf-year Report
22nd Sep 20171:00 pmRNSHolding(s) in Company
19th Sep 20174:55 pmRNSHolding(s) in Company
11th Sep 20177:00 amRNSDirectorate Change
22nd Aug 20173:17 pmRNSAnnouncement of 2017 interim results
17th Aug 20174:19 pmRNSHolding(s) in Company
15th Aug 20175:58 pmRNSHolding(s) in Company
11th Aug 20176:20 pmRNSHolding(s) in Company
8th Aug 20173:59 pmRNSHolding(s) in Company
8th Aug 201710:02 amRNSHolding(s) in Company
3rd Aug 20179:02 amRNSHolding(s) in Company
1st Aug 201712:24 pmRNSHolding(s) in Company
31st Jul 20172:57 pmRNSHolding(s) in Company
27th Jul 20176:28 pmRNSHolding(s) in Company
18th Jul 201710:49 amRNSHolding(s) in Company
18th Jul 20177:00 amRNSCarillion JV awarded two further HESTIA contracts
17th Jul 20177:19 amRNSHS2 Contract Award
17th Jul 20177:00 amRNSCarillion appoints EY to support strategic review
14th Jul 201712:20 pmRNSHolding(s) in Company
14th Jul 20177:00 amRNSAppointment of Joint Financial Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.